EXECUTIVE BOARD

Dr. Henri Michael von Blanquet, M.D., MaHM (Founder)

Dipl.-Kfm. Patrick Hofmann (Founder)

ADVISORY BOARD

Dr. Scott Kahn, PhD – former Chief Information Officer of illumina

Dr. Razelle Kurzrock, M.D, Director, Center for Personalized Cancer Therapy and Clinical Trials Office & Senior Deputy Director for Clinical Science, Moores Cancer Center & Chief, Division of Hematology-Oncology, Department of Medicine

Dr. Erwin Boettinger, M.D., PhD, Head & Professor “Digital Health & Precision Medicine”, Faculty of Digital-Engineering of Hasso-Plattner-Institute and University of Potsdam

Dr. Thomas Gottwald, M.D., PhD, Professor of Surgery – Exceutive Board Ovesco  AG

Dr. Clemens Guth, M.D., MBA – Managing Director Artemed Hospital Group

Dr. Norbert Klusen, Professor – former CEO of Techniker Krankenkasse

BOARD OF EXPERTS

Gabriel A. Bien-Willner, M.D., PhD, FCAP – Founder Bien-Willner Physicians Group for Molecular Diagnostics (USA)

 

BOARD OF TRUSTEES AND INVESTORS

Dr. Antonius Schuh, PhD, Founder Global Source Ventures, LLC

N.N.

PROFIT AND NON-PROFIT PARTNERS

Roger Sturm, CEO QB-International

Alois Steidel, CEO KMS Vertrieb und Services AG, Board of Directors cdgw.de

FRIENDS OF THE PRECISION MEDICINE ALLIANCE